Literature DB >> 16914845

Clinicopathological analysis of dementia disorders in the elderly--an update.

Kurt A Jellinger1.   

Abstract

A retrospective clinico-pathological study of a consecutive autopsy series of 1050 elderly demented individuals (mean age 83.4 +/- 6.0 years; MMSE < 20) was performed. Clinical diagnoses were probable or possible Alzheimer disease (62.9%), nonspecific degenerative dementia (10.4%), vascular dementia (10%), Parkinson disease with dementia (9.5%), 1.5% mixed dementia, and 5.7% other disorders. At autopsy, 86% revealed Alzheimer-related pathology, but only 42.8% showed "pure" Alzheimer disease, with additional cerebrovascular lesions in 22.6% and Lewy body pathology in 10.8%, while among 660 cases of clinically suspected Alzheimer disease, Alzheimer pathology was seen in 93%, only 44.7% in "pure" form, and additional vascular lesions and Lewy bodies in 27.7 and 10%, respectively. The non-Alzheimer cases included Huntington and Creutzfeldt-Jakob disease, frontotemporal dementias, and others. These and other recent data indicate that in patients with the clinical diagnosis of Alzheimer disease its combination with cerebrovascular lesions and Lewy body pathologies is rather frequent. Comparison of clinical and postmortem diagnoses revealed postmortem confirmation of Alzheimer disease in 93%, of mixed and vascular dementia in 60 and 52.3%, respectively. 78% of clinically suspected degenerative dementias were pathologically definite Alzheimer disease, while in the clinical Parkinson + dementia group dementia with Lewy bodies accounted for 35%, Parkinson+Alzheimer disease, and "pure" Alzheimer disease for 29%, each. A sample of 207 prospectively studied elderly showed significant negative correlation between the preterminal psychostatus assessed by MMSE and the neuritic Braak stages, with a broad "gray" zone of Alzheimer lesions in mildly to moderately demented subjects. Similar relations between CDR and Braak stages were seen in very old subjects. The present study and the results of other recent series indicate increasing agreement between clinical and autopsy diagnoses in demented aged individuals with variable accuracy rates for different forms of dementia disorders.

Entities:  

Mesh:

Year:  2006        PMID: 16914845     DOI: 10.3233/jad-2006-9s308

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  44 in total

1.  Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing.

Authors:  David Dolan; Juan Troncoso; Susan M Resnick; Barbara J Crain; Alan B Zonderman; Richard J O'Brien
Journal:  Brain       Date:  2010-07-20       Impact factor: 13.501

2.  An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells.

Authors:  Walter J Lukiw; Yuhai Zhao; Jian Guo Cui
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

3.  Does registration of serial MRI improve diagnosis of dementia?

Authors:  Josephine Barnes; L Anne Mitchell; Jonathan Kennedy; Antonio J Bastos-Leite; Suzie Barker; Manja Lehmann; R Chris Nordstrom; Chris Frost; Joseph R Smith; Ellen Garde; Martin N Rossor; Nick C Fox
Journal:  Neuroradiology       Date:  2010-02-27       Impact factor: 2.804

4.  The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset.

Authors:  Joann T Tschanz; Maria C Norton; Peter P Zandi; Constantine G Lyketsos
Journal:  Int Rev Psychiatry       Date:  2013-12

Review 5.  [Prevention of cognitive decline and dementia by treatment of risk factors].

Authors:  Claus Escher; Frank Jessen
Journal:  Nervenarzt       Date:  2019-09       Impact factor: 1.214

6.  [Guideline-adherent inpatient psychiatric psychotherapeutic treatment of behavioral and psychological symptoms of dementia : Normative definition of personnel requirements].

Authors:  K Radenbach; J Retzlik; S H Meyer-Rötz; C Wolff-Menzler; J Wolff; H Esselmann; F Godemann; M Riemenschneider; J Wiltfang; F Jessen
Journal:  Nervenarzt       Date:  2017-09       Impact factor: 1.214

7.  Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset.

Authors:  Josephine Barnes; Bradford C Dickerson; Chris Frost; Lize C Jiskoot; David Wolk; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2015-04-24       Impact factor: 21.566

8.  Clinicopathologic study of Alzheimer's disease: Alzheimer mimics.

Authors:  Yong S Shim; Catherine M Roe; Virginia D Buckles; John C Morris
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 9.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

10.  Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND).

Authors:  Blossom Cm Stephan; Fiona E Matthews; Kay-Tee Khaw; Carole Dufouil; Carol Brayne
Journal:  Alzheimers Res Ther       Date:  2009-07-09       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.